NOVARTIS Stock Price Prediction

<div class='circular--portrait' style='background:#347AFC;color: #ffffff;font-size:4em;padding-top: 25px;;'>NI</div>
NOVARTIND -- India Stock  

INR 555.65  1.80  0.33%

NOVARTIS INDIA LTD stock price prediction is an act of determining the future value of NOVARTIS INDIA shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of NOVARTIS INDIA stock future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with NOVARTIS INDIA LTD, which may create opportunities for some arbitrage if properly timed. Additionally, see NOVARTIS INDIA Basic Forecasting Models to cross-verify your projections.

Search Stock Price Prediction

 
Refresh
The NOVARTIS stock price prediction module also provides an analysis of price elasticity to changes in media outlook on NOVARTIS INDIA over a specific investment horizon. Using NOVARTIS INDIA hype-based prediction, you can estimate the value of NOVARTIS INDIA LTD from the perspective of NOVARTIS INDIA response to recently generated media hype and the effects of current headlines on its competitors.
Bollinger
Band Projection (param)
LowerMiddle BandUpper
545.55558.39571.24
Details
Hype
Prediction
LowEstimated ValueHigh
551.64555.65559.66
Details
Intrinsic
Valuation
LowReal ValueHigh
457.11461.12611.22
Details
Naive
Forecast
LowNext ValueHigh
579.89583.90587.90
Details

NOVARTIS INDIA After-Hype Price Density Analysis

 Next price density 
      Expected price to next headline 

NOVARTIS INDIA Estimiated After-Hype Price Volatility

Current Value
555.65
27th of May 2020
551.64
Downside
555.65
After-hype Price
559.66
Upside
NOVARTIS INDIA is very steady asset. Analysis and calculation of next after-hype price of NOVARTIS INDIA LTD is based on 3 months time horizon.

NOVARTIS INDIA Stock Price Prediction Analysis

Daily Expected returnPeriod VolatilityHype elasticityRelated hype elasticityAverage news densityRelated news densityNext Expected Hype
 0.02  4.01  0.00   0.00  0 Events / Month0 Events / MonthUncertain
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
555.65555.650.00 
0.00  

NOVARTIS INDIA Hype Timeline

NOVARTIS INDIA LTD is now traded for 555.65on Bombay Stock Exchange of India. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. NOVARTIS INDIA LTD is anticipated not to react to the next headline with price going to stay at about the same level and average media hype impact volatility of 0.0%. The immediate return on the next news is anticipated to be very small where as daily expected return is now at -0.02%. The volatility of relative hype elasticity to NOVARTIS INDIA is about 0.0%%. The volatility of related hype on NOVARTIS INDIA is about 0.0% with expected price after next announcement by competition of 555.65. The company has price-to-book ratio of 1.89. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NOVARTIS INDIA LTD recorded earning per share (EPS) of 9.26. The entity last dividend was issued on 2019-07-31. Assuming 30 trading days horizon, the next anticipated press release will be uncertain.
Additionally, see NOVARTIS INDIA Basic Forecasting Models to cross-verify your projections.

Additional Predictive Modules

About NOVARTIS INDIA Predictive Indicators

The successful prediction of NOVARTIS INDIA stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NOVARTIS INDIA LTD, already reflect all publically available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'text-book' version of this hypothesis and continually tries to find mispriced stocks to increase returns on his or her portfolios. We use internally-developed statistical techniques to arrive at the intrinsic value of BlackBerry Limited based on analysis of NOVARTIS INDIA hews, social hype, and general headline patterns together with widely used predictive technical indicators. We also calculate exposure to NOVARTIS INDIA's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NOVARTIS INDIA's related companies.
Additionally, see NOVARTIS INDIA Basic Forecasting Models to cross-verify your projections. Please also try Equity Analysis module to research over 250,000 global equities including funds, stocks and etfs to find investment opportunities.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page